CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 49 enrolled
Drug / intervention
MRI scanning +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01569568
NCT01569568N/ACompleted

Investigation of Brain Nitrogen in Partial Ornithine Transcarbamylase Deficiency (OTCD) Using 1 H MRS, DTI, and fMRI

Andrea Gropman·observational·Posted Apr 3, 2012·Updated Mar 8, 2024

In Brief

An observational study evaluating MRI scanning and Cognitive testing for Ornithine Transcarbamylase Deficiency. Completed, enrolled 49 participants.

Detailed Summary

The purpose of this study is to use various types of MRI and cognitive testing to evaluate changes in the brain and cognitive function that occur in subjects with ornithine transcarbamylase deficiency (OTCD) relative to healthy individuals

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
Countries--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedApr 3, 2012
Enrollment StartSep 1, 2010
Primary CompletionAug 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 14.2 years ago

Interventions

MRI scanningother

1H MRS, DTI, FMRI

Cognitive testingbehavioral

Behavioral testing